Med. 12, 342–347, 2006) and elevated levels of creatine phosphokinase seen in certain people receiving Glybera (alipogene tiparvovec) from Netherlands-based Amsterdam Molecular Therapeutics ...

Efficacy findings from the phase 2 AGAVE-201 support the use of axatilimab, which was approved by the FDA for recurrent or ...

Other abnormal readings may or may not indicate a problem. A high lev­el of creatine phosphokinase, a muscle enzyme, can signal a heart or muscular ailment—or it can mean you worked out shortly ...

Frightened, Furlan went to the doctor. A test revealed her level of creatine phosphokinase — an enzyme released into the blood when muscles are damaged — was 50 times normal. It indicated a ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to ...

The epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-free survival ...

The epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-free survival ...

Nat Clin Pract Nephrol. 2006;2(3):136-148. Hypophosphatemia associated with primary hyperparathyroidism is usually of moderate severity; increased urinary phosphate excretion is balanced by ...

Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and ...